%0 Conference Paper
%A Glaeser, Eva
%A Kilimann, Ingo
%A Platen, Moritz
%A Hoffmann, Wolfgang
%A Brosseron, Frederic
%A Bürger, Katharina
%A Coenjaerts, Marie
%A Düzel, Emrah
%A Ewers, Michael
%A Fließbach, Klaus
%A Frommann, Ingo
%A Gemenetzi, Maria
%A Glanz, Wenzel
%A Hellmann-Regen, Julian
%A Incesoy, Enise I
%A Janowitz, Daniel
%A Jessen, Frank
%A Peters, Oliver
%A Priller, Josef
%A Ramirez, Alfredo
%A Schneider, Anja
%A Spottke, Annika
%A Spruth, Eike Jakob
%A Teipel, Stefan
%A Wagner, Michael
%A Michalowsky, Bernhard
%T The Economic Burden of Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Dementia: Excess Costs and Associated Clinical and Risk Factors
%J Alzheimer's and dementia
%V 21
%N Suppl 6
%@ 1552-5260
%M DZNE-2025-01481
%P e100774
%D 2025
%X This study assessed costs and cost-associated factors in patients with subjective cognitive decline (SCD), mild cognitive impairment (MCI) and Alzheimer's Disease (AD) dementia compared to healthy controls.Clinical data, risk factors, healthcare resource use and informal care provision were assessed in the DELCODE study. Costs were calculated from payer and societal perspectives, with multivariate regression analyses identifying cost-associated factors.Societal costs were elevated by 50
%B Alzheimer’s Association International Conference
%C 27 Jul 2025 - 31 Jul 2025, Toronto (Canada)
Y2 27 Jul 2025 - 31 Jul 2025
M2 Toronto, Canada
%K Humans
%K Male
%K Female
%K Cognitive Dysfunction: economics
%K Alzheimer Disease: economics
%K Aged
%K Health Care Costs: statistics & numerical data
%K Public Health: economics
%K Risk Factors
%K Cost of Illness
%K Aged, 80 and over
%K Middle Aged
%F PUB:(DE-HGF)1 ; PUB:(DE-HGF)16
%9 AbstractJournal Article
%$ pmid:41435114
%2 pmc:PMC12726759
%R 10.1002/alz70860_100774
%U https://pub.dzne.de/record/283074